Dialysis Clinic Inc Northside is a medicare approved dialysis facility center in Atlanta, Georgia and it has 23 dialysis stations. It is located in Fulton county at 870 Northside Drive Ste 300, Atlanta, GA, 30318. You can reach out to the office of Dialysis Clinic Inc Northside at (404) 888-4520. This dialysis clinic is managed and/or owned by Dialysis Clinic, Inc.. Dialysis Clinic Inc Northside has the following ownership type - Non-Profit. It was first certified by medicare in July, 1981. The medicare id for this facility is 112522 and it accepts patients under medicare ESRD program.
| Name | Dialysis Clinic Inc Northside |
|---|---|
| Location | 870 Northside Drive Ste 300, Atlanta, Georgia |
| No. of Dialysis Stations | 23 |
| Medicare ID | 112522 |
| Managed By | Dialysis Clinic, Inc. |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| 870 Northside Drive Ste 300, Atlanta, Georgia, 30318 | |
| (404) 888-4520 | |
News Archive
A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
A piece of the puzzle of how nerves find their way across the midline of the brain and spinal cord in a developing embryo has been found by Medical College of Georgia researchers.
In this Kaiser Health News consumer column, Michelle Andrews writes: "Many people may not realize that, in some ways, the new health law will expand options for patients at the end of life.
› Verified 5 days ago
| NPI Number | 1992733612 |
| Doing Business As | Dialysis Clinic Inc. |
| Address | 870 Northside Drive Atlanta, Georgia, 30318 |
| Phone Number | (404) 888-4520 |
News Archive
A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
A piece of the puzzle of how nerves find their way across the midline of the brain and spinal cord in a developing embryo has been found by Medical College of Georgia researchers.
In this Kaiser Health News consumer column, Michelle Andrews writes: "Many people may not realize that, in some ways, the new health law will expand options for patients at the end of life.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 44 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 18 |
News Archive
A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
A piece of the puzzle of how nerves find their way across the midline of the brain and spinal cord in a developing embryo has been found by Medical College of Georgia researchers.
In this Kaiser Health News consumer column, Michelle Andrews writes: "Many people may not realize that, in some ways, the new health law will expand options for patients at the end of life.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 83 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 705 |
| Percentage of adult patients getting regular hemodialysis at the center | 90 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
A piece of the puzzle of how nerves find their way across the midline of the brain and spinal cord in a developing embryo has been found by Medical College of Georgia researchers.
In this Kaiser Health News consumer column, Michelle Andrews writes: "Many people may not realize that, in some ways, the new health law will expand options for patients at the end of life.
› Verified 5 days ago
| Adult patients getting regular peritoneal dialysis at the center | 4 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 29 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
A piece of the puzzle of how nerves find their way across the midline of the brain and spinal cord in a developing embryo has been found by Medical College of Georgia researchers.
In this Kaiser Health News consumer column, Michelle Andrews writes: "Many people may not realize that, in some ways, the new health law will expand options for patients at the end of life.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Dialysis Clinic Inc Northside with elevated calcium levels.
| Patients with hypercalcemia | 88 |
| Hypercalcemia patient months | 759 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 3 |
| Patients with Serumphosphor | 87 |
| Patients with Serumphosphor less than 3.5 mg/dL | 8 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 36 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 16 |
| Patients with Serumphosphor greater than 7 mg/dL | 17 |
News Archive
A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
A piece of the puzzle of how nerves find their way across the midline of the brain and spinal cord in a developing embryo has been found by Medical College of Georgia researchers.
In this Kaiser Health News consumer column, Michelle Andrews writes: "Many people may not realize that, in some ways, the new health law will expand options for patients at the end of life.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 114 |
| Patient months included in arterial venous fistula and catheter summaries | 582 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 53 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 10 |
News Archive
A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
A piece of the puzzle of how nerves find their way across the midline of the brain and spinal cord in a developing embryo has been found by Medical College of Georgia researchers.
In this Kaiser Health News consumer column, Michelle Andrews writes: "Many people may not realize that, in some ways, the new health law will expand options for patients at the end of life.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 82 |
| Hospitalization Rate in facility | 182.9 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 314.3 |
| Hospitalization Rate: Lower Confidence Limit | 109.6 |
News Archive
A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
A piece of the puzzle of how nerves find their way across the midline of the brain and spinal cord in a developing embryo has been found by Medical College of Georgia researchers.
In this Kaiser Health News consumer column, Michelle Andrews writes: "Many people may not realize that, in some ways, the new health law will expand options for patients at the end of life.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at Dialysis Clinic Inc Northside were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 25 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 36.9 |
| Readmission Rate: Lower Confidence Limit | 15.4 |
News Archive
A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
A piece of the puzzle of how nerves find their way across the midline of the brain and spinal cord in a developing embryo has been found by Medical College of Georgia researchers.
In this Kaiser Health News consumer column, Michelle Andrews writes: "Many people may not realize that, in some ways, the new health law will expand options for patients at the end of life.
› Verified 5 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Dialysis Clinic Inc Northside get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .76 (As Expected) |
| SIR: Upper Confidence Limit | 1.67 |
| SIR: Lower Confidence Limit | .28 |
News Archive
A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
A piece of the puzzle of how nerves find their way across the midline of the brain and spinal cord in a developing embryo has been found by Medical College of Georgia researchers.
In this Kaiser Health News consumer column, Michelle Andrews writes: "Many people may not realize that, in some ways, the new health law will expand options for patients at the end of life.
› Verified 5 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Dialysis Clinic Inc Northside's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 77 |
| Transfusion Rate in facility | 18.6 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 64.8 |
| Transfusion Rate: Lower Confidence Limit | 6.2 |
News Archive
A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
A piece of the puzzle of how nerves find their way across the midline of the brain and spinal cord in a developing embryo has been found by Medical College of Georgia researchers.
In this Kaiser Health News consumer column, Michelle Andrews writes: "Many people may not realize that, in some ways, the new health law will expand options for patients at the end of life.
› Verified 5 days ago
The rate of mortality show you whether patients who were being treated regularly at Dialysis Clinic Inc Northside lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 491 |
| Mortality Rate in facility | 19.1 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 25.3 |
| Mortality Rate: Lower Confidence Limit | 14.1 |
News Archive
A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
A piece of the puzzle of how nerves find their way across the midline of the brain and spinal cord in a developing embryo has been found by Medical College of Georgia researchers.
In this Kaiser Health News consumer column, Michelle Andrews writes: "Many people may not realize that, in some ways, the new health law will expand options for patients at the end of life.
› Verified 5 days ago
Dialysis Clinic Inc Northside Location: 870 Northside Drive Ste 300, Atlanta, Georgia, 30318 Phone: (404) 888-4520 |
Southwest Atlanta Dialysis Center Location: 3620 Martin Luther King Jr Drive Sw, Atlanta, Georgia, 30331 Phone: (404) 696-7303 |
Ford Factory Square Dialysis Location: 567 North Ave Ne Suite 100, Atlanta, Georgia, 30308 Phone: (404) 745-9581 |
News Archive
A new simple blood test for brain tumors that could be used by GPs in primary care is being developed thanks to funding of nearly £500,000 by Cancer Research UK.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
A piece of the puzzle of how nerves find their way across the midline of the brain and spinal cord in a developing embryo has been found by Medical College of Georgia researchers.
In this Kaiser Health News consumer column, Michelle Andrews writes: "Many people may not realize that, in some ways, the new health law will expand options for patients at the end of life.
› Verified 5 days ago